DC HEALTHCARE HOLDINGS BERHAD
KLSE (MYR): DCHCARE (0283)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.175
Today's Change
+0.005 (2.94%)
Day's Change
0.17 - 0.185
Trading Volume
3,818,900
Financial
Market Cap
171 Million
NOSH
979 Million
Latest Quarter
30-Sep-2024 [#3]
Announcement Date
26-Nov-2024
Next Quarter
31-Dec-2024
Est. Ann. Date
27-Feb-2025
Est. Ann. Due Date
01-Mar-2025
QoQ | YoY
67.92% | 21.45%
Revenue | NP to SH
56,716.000 | -17,846.000
RPS | P/RPS
5.80 Cent | 3.02
EPS | P/E | EY
-1.82 Cent | -9.60 | -10.42%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.05 | 3.50
QoQ | YoY
3.19% | -591.22%
NP Margin | ROE
-31.47% | -36.47%
F.Y. | Ann. Date
30-Sep-2024 | 26-Nov-2024
Latest Audited Result
31-Dec-2023
Announcement Date
30-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
30-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
67,789.000 | 2,560.000
RPS | P/RPS
6.93 Cent | 2.53
EPS | P/E | EY
0.26 Cent | 66.90 | 1.49%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.06 | 2.86
YoY
null%
NP Margin | ROE
3.78% | 4.28%
F.Y. | Ann. Date
31-Dec-2023 | 27-Feb-2024
Revenue | NP to SH
52,190.666 | -22,364.000
RPS | P/RPS
5.33 Cent | 3.28
EPS | P/E | EY
-2.29 Cent | -7.66 | -13.06%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
23.52% | -561.68%
NP Margin | ROE
-42.85% | -44.80%
F.Y. | Ann. Date
30-Sep-2024 | 26-Nov-2024
Show?
| Last 10 FY Result | ||||||
| AQR | T4Q | 31/12/23 | 31/12/22 | CAGR | ||
|---|---|---|---|---|---|---|
| Revenue | 52,190 | 56,716 | 67,789 | 0 | - | |
| PBT | -22,364 | -17,042 | 5,054 | 0 | - | |
| Tax | 0 | -804 | -2,494 | 0 | - | |
| NP | -22,364 | -17,846 | 2,560 | 0 | - | |
| - | ||||||
| NP to SH | -22,364 | -17,846 | 2,560 | 0 | - | |
| - | ||||||
| Tax Rate | - | - | 49.35% | - | - | |
| Total Cost | 74,554 | 74,562 | 65,229 | 0 | - | |
| - | ||||||
| Net Worth | 49,919 | 48,931 | 59,777 | 0 | - | |
| Equity | ||||||
| AQR | T4Q | 31/12/23 | 31/12/22 | CAGR | ||
|---|---|---|---|---|---|---|
| Net Worth | 49,919 | 48,931 | 59,777 | 0 | - | |
| NOSH | 998,392 | 978,636 | 996,300 | 0 | - | |
| Ratio Analysis | ||||||
| AQR | T4Q | 31/12/23 | 31/12/22 | CAGR | ||
|---|---|---|---|---|---|---|
| NP Margin | -42.85% | -31.47% | 3.78% | 0.00% | - | |
| ROE | -44.80% | -36.47% | 4.28% | 0.00% | - | |
| Per Share | ||||||
| AQR | T4Q | 31/12/23 | 31/12/22 | CAGR | ||
|---|---|---|---|---|---|---|
| RPS | 5.23 | 5.80 | 6.80 | 0.00 | - | |
| EPS | -2.24 | -1.82 | 0.26 | 0.00 | - | |
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | - | |
| NAPS | 0.05 | 0.05 | 0.06 | 0.02 | 199.99% | |
| Adjusted Per Share Value based on latest NOSH - 998,392 | ||||||
| AQR | T4Q | 31/12/23 | 31/12/22 | CAGR | ||
|---|---|---|---|---|---|---|
| RPS | 5.33 | 5.80 | 6.93 | 0.00 | - | |
| EPS | -2.29 | -1.82 | 0.26 | 0.00 | - | |
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | - | |
| NAPS | 0.051 | 0.05 | 0.0611 | 0.02 | 205.49% | |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
Be the first to like this. Showing 50 of 907 comments
Surface advertising only. Internal a lot of problems. Even their interviews are low standard, main problem many patients went to other aesthetic clinic, and complain Dr Chong quality, rather burn their left over package than going back. This is so bad
2 months ago
Yes. Saw all these naive comments without facts or research. Cannot tahan joined and gave my view. That’s called keyboard warrior FetcoveXX?
2 months ago
Jimmy7890 is from another aesthetic clinic which is not recognized by the Malaysia Book of Records ? 🤔 Why so jealous of DC healthcare getting interviewed?
2 months ago
hahaha sour comment spotted! DCHCARE doubling down on penang healthcare hub/tourism, see you above 0.20 soon
2 months ago
How can investors believe that after just one year the price fell cheaper than the IPO price?
Dr Chong pun cong jugak ke?
🤔🤔🤔
2 months ago
The company may use the funds saved from cancelling the RM70 million acquisition of I Bella Sdn Bhd for share buybacks 😁
2 months ago
@Travisbravis
big announcement soon, dr chong wont let us down
@marcelle5
Dr chong will push the share price up lah, ez tp 0.20
.........................................................................................................
Just after 1 year the market share price felt below IPO price..
also the technical chart stick all negative shown STRONG SELLLLLLLLLL...
All in just 1 yearrrrrrr...
huhuhuhu
2 months ago
Traders are often short-sighted. Look at Gen Z nowadays, the aesthetic industry is definitely booming
2 months ago
The new year is coming. People will go to the clinic to redeem aesthetic services 😁
2 months ago
Oops, still not 20cents yet, dropped further from my last comment. Good luck to Dr Chong paid fan 😄
2 months ago
Dow Jones
Dow Jones Industrial Average
42,740.42
-324.80
0.75%
Nasdaq
NASDAQ Composite
18,315.58
-187.10
1.01%
2 months ago
Target Price: RM0.200, RM0.220
Last closing price: RM0.180
Potential return: 11.1%, 22.2%
Support: RM0.175
Stop Loss: RM0.150
Huhuhuu
Still below IPO price..
1 month ago
Dow member McDonald’s
closed more than 5% lower. The Centers for Disease Control and Prevention said late Tuesday that an E. coli outbreak tied to the fast-food giant’s Quarter Pounder burgers has resulted in 10 hospitalizations and one death.
1 month ago
New IPO coming similar to DCHCARE..
METRO HEALTHCARE BERHD..
Same IPO price with DCH..
Going down also like DCH..
Huhuhu
1 month ago
DC Healthcare Holdings Berhad, has been actively expanding its operations by opening new branches across Malaysia. Their aggressive growth strategy has led to increased administrative and advertising expenses, contributing to recent financial losses. For instance, in the fourth quarter ended December 31, 2023, the company reported a net loss of RM1.07 million, despite achieving a revenue of RM17.57 million.
The share price has experienced a significant decline, closing at RM0.16 on November 8, 2024, marking a 69.23% drop over the past year. This downturn can be attributed to the financial losses and market concerns regarding the sustainability of its rapid expansion.
But I think the company's strategic initiatives, such as the establishment of new clinics in key locations like Johor Bahru and Ipoh, aim to tap into high-income markets and drive future revenue growth. Additionally, the implementation of an Employee Share Option Scheme (ESOS) is intended to align employee interests with company performance, potentially enhancing operational efficiency and profitability.
And I think, the share price may remain under pressure in the short term due to ongoing financial challenges and market scepticism. However, if the company's expansion efforts lead to increased market share and profitability, and if the ESOS successfully motivates employees to drive performance, there is potential for share price recovery in the medium to long term.
I think this will rebound sooner than later by 2nd Quarter 2025
1 month ago
Since its listing on Bursa, DCHCARE has encountered considerable financial challenges, reporting a net loss of RM18.49 million over the past twelve months and maintaining a negative profit margin of 32.82%. The stock has exhibited marked volatility, with weekly fluctuations averaging 10%, placing it among the top 25% of the most volatile stocks on the Malaysian market.
I believe the company’s strategy to expand its aesthetic services footprint—from 12 outlets in Q2 2023 to 17 in Q2 2024—alongside the launch of new product lines under the Ten Doctors brand and four additional outlets dedicated to slimming services, shows a strong commitment to growth. This increase, bringing the total to 21 outlets in Q2 2024 compared to the previous year’s 12, could create favourable prospects for financial recovery. However, the success of these initiatives will likely depend on broader market conditions and prevailing investor sentiment.
1 month ago
GeraiRamlyburger
Wah drchong still got money open new branch
***********************************************************
IPO Price 0.25
now 0.165
Lot peoples call sell..
Dr Chong got money maaaa
1 week ago
With the opening of the George Town clinic, DC Healthcare now operates a total of 18 medical aesthetic clinics, including the addition of a new skin and wellness centre, and 4 DC Body outlets nationwide
1 week ago
They opened a new clinic branch.
They let the market price stay below the IPO price.
Then the profits are distributed only among themselves in the form of bonuses.
Many ikan bilis cut loss..
cabuttttttttttt
1 week ago
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
Stock Market Enthusiast
Top 3 AI/Data Center Newsflow for the 3rd Week of December - #TENAGA, #YTL, #YTLPOWER
2
Rakuten Trade Research Reports
3
save malaysia!
4
Good Articles to Share
5
Good Articles to Share
6
Good Articles to Share
Gaza ceasefire deal 'closer than ever', says Hamas and two allies
7
Good Articles to Share
Ryan Serhant makes bold pitch to fix the housing ‘affordability crisis’
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
mudaBubu
Q3 result good then confirm can fly higher than 20 sen
2024-09-23 16:48